By listening for ghostly radio echoes from the early Universe, scientists believe future Moon missions could determine what dark matter really is.

A proposed constellation of satellites has astronomers very worried. Unlike satellites that reflect sunlight and produce light pollution as an unfortunate byproduct, the ones by US startup Reflect Orbital would produce light pollution by design.
The company promises to produce “sunlight on demand” with mirrors that beam sunlight down to Earth so solar farms can operate after sunset.
It plans to start with an 18-metre test satellite named Earendil-1 which the company has applied to launch in 2026. It would eventually be followed by about 4,000 satellites in orbit by 2030, according to the latest reports.
A new Android spyware called ClayRat is luring potential victims by posing as popular apps and services like WhatsApp, Google Photos, TikTok, and YouTube.
The malware is targeting Russian users through Telegram channels and malicious websites that appear legitimate. It can steal SMS meessages call logs, notifications, take pictures, and even make phone calls.
Malware researchers at mobile security company Zimperium say that they documented more than 600 samples and 50 distinct droppers over the past three months, indicating an active effort from the attacker to amplify the operation.
A cybercrime gang tracked as Storm-2657 has been targeting university employees in the United States to hijack salary payments in “pirate payroll” attacks since March 2025.
Microsoft Threat Intelligence analysts who spotted this campaign found that the threat actors are targeting Workday accounts; however, other third-party human resources (HR) software-as-a-service (SaaS) platforms could also be at risk.
“We’ve observed 11 successfully compromised accounts at three universities that were used to send phishing emails to nearly 6,000 email accounts across 25 universities,” Microsoft said in a Thursday report.
Researchers at the Francis Crick Institute and Vividion Therapeutics have identified chemical compounds that can precisely block the interaction between the major cancer-driving gene RAS and a key pathway for tumor growth.
Now entering the first clinical trial in humans, if found to be safe and effective, these drugs could be used to treat many different types of cancers while avoiding effects on healthy cells.
A gene called RAS, which kickstarts cell growth pathways, is mutated in around one in five cancers. Mutated versions of the gene lock the RAS protein in an activated state, telling the cancer cell to keep growing bigger and keep dividing.
Tumors are not a comfortable place to live: oxygen deficiency, nutrient scarcity, and the accumulation of sometimes harmful metabolic products constantly stress cancer cells.
A research team from the German Cancer Research Center (DKFZ) and the Institute of Molecular Pathology (IMP) in Vienna has now discovered that the acidic pH value in tumor tissue—known as acidosis—is a decisive factor in how pancreatic cancer cells adapt their energy metabolism in order to survive under these adverse conditions.
The results are published in the journal Science.